Biggest News Aggregation in the World
📰 Gb Sciences News

Page 5 - Gb Sciences News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Gb Sciences. Real-time updates on events, politics, business and more.

Newswire's Guided Tour Client, GB Sciences, Builds Brand Awareness with Feature Article in Pharma's

GB Sciences Logo GB Sciences Logo NEW YORK - April 29, 2021 - (Newswire.com) GB Sciences, a client that's part of Newswire's Earned Media Advantage Guided Tour program, was recently featured in a Pharma's Almanac article discussing how the company has successfully incubated a biot...
Pharma Almanacprovides Charlie Terenzio Marketing Communications At Newswire Gb Sciences Marketing Communications Gb Sciences Inc

GB Sciences Featured & Speaking at the SACHS Associates' 4th Annual Neuroscience Innovation Forum

GB Sciences Featured & Speaking at the SACHS Associates 4th Annual Neuroscience Innovation Forum LAS VEGAS, NV / ACCESSWIRE / April 27, 2021 / GB Sciences (GBS), Inc. (OTCQB:GBLX), a leading phytomedicine research and biopharmaceutical development company, will be featured during the SPOTLIGHT SHOWCASE at the SACHS Associates 4th Annual Neuroscience Innovation Forum (NIF) for Business Development, Licensing & Investment from April 28 to April 30. The SACHS NIF, which is entirely virtual, will ...
Mark Demitrack Norbert Riedel Seth Lederman Randall Stevens Las Vegas Pradeep Banerjee

GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

Press release content from Newswire. The AP news staff was not involved in its creation. GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals April 20, 2021 GMT GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals LAS VEGAS - April 20, 2021 - ( Newswire.com ) GB Sciences, Inc. (OTCQB: GBLX) and Purisys, LLC, the global industry leader in ultra-high purity, pharmaceutical g...
United States Purisys Apis Josh Hoerner Las Vegas Exchange Commission Gb Sciences
Source: apnews.com

GB Sciences, Inc.: GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals

GB Sciences, Inc.: GB Sciences and Purisys Announce Preferred Supplier Relationship to Advance Cannabinoid-Containing Pharmaceuticals Purisys will supply ultra-high purity cannabinoids for use in GB Sciences cannabinoid-containing, optimized therapeutic mixtures (OTM). LAS VEGAS, NV / ACCESSWIRE / April 20, 2021 / GB Sciences, Inc. (OTCQB:GBLX) and Purisys, LLC, the global industry leader in ultra-high purity, pharmaceutical grade cannabinoid supply, today announced that GB Sciences has selecte...
United States Purisys Apis Josh Hoerner Las Vegas Exchange Commission Gb Sciences

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Study Shows that Cannabis Extracts May Help in the Prevention of Certain CV19 Symptoms

Study Shows that Cannabis Extracts May Help in the Prevention of Certain CV19 Symptoms FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, March 9, 2021 /PRNewswire/ -- After facing scrutiny last spring, new research suggests that using cannabis to help treat and prevent COVID-19 isnt so far-fetched after all. Researchers at the University of Lethbridge are advancing to clinical trials after study results revealed that certain cannabis strains might help prevent COVID-19 patie...
United States Kostenloser Wertpapierhandel Norbert Kaminski Olga Kovalchuk Tilray Inc University Of Lethbridge

Cannabis-based drug to fight COVID-19 inflammation

MORE LANSING, MI. — Parts of the marijuana plant could be a key to treating one of COVID-19’s deadly symptoms.  The immune system responds when exposed to COVID-19, but sometimes so aggressively it affects lung function and makes it harder to breathe. That’s where a new drug containing cannabinoids, a family of compounds contained in the marijuana plant, comes in.  Norbert Kaminski, a Michigan State University professor of pharmacology and toxicology, is working with GB Sci...
Norbert Kaminski Gb Sciences Michigan State University Drug Administration Cytokine Release Syndrome Independent New Drug

Pharmaceutical Grade Marijuana Market Analysis, Growing Demand and Business Outlook 2021 to 2025 – KSU

tanmayFebruary 18, 2021  The Global Pharmaceutical Grade Marijuana Market Research Report Forecast 2021 – 2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The report also takes into account the impact of the novel COVID-19 pandemic on the Pharmaceutical Grade Marijuana market and offers a clear assessment of the projected market fl...
Global Pharmaceutical Grade Marijuana Market Research Report Corbus Pharmaceuticals Biotechnologies Inc Research Development Centers Canopy Growth Corporation Gw Pharmaceuticals

MSU researcher, GB Sciences developing cannabis-based COVID-19 drug

LANSING — Parts of the marijuana plant could be a key to treating one of COVID-19’s deadly symptoms.  The immune system responds when exposed to COVID-19, but sometimes so aggressively it affects lung function and makes it harder to breathe.  That’s where a new drug containing cannabinoids, a family of compounds contained in the marijuana plant, comes in.  Norbert Kaminski, a Michigan State University professor of pharmacology and toxicology, is working with GB Sciences, a bioph...
Mark Johnson Lansing Norbert Kaminski Gb Sciences Michigan State University Drug Administration Lansing State

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science